These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibition of the graft-versus-host reaction. III. Altered in vivo distribution of spleen cells pretreated with Fab fragments of antithymocyte globulin. Richie ER, Monié HJ, Trentin JJ, Taub RN. Transplantation; 1975 Feb; 19(2):115-20. PubMed ID: 235162 [Abstract] [Full Text] [Related]
4. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice. Peres A, Nestel FP, Seemayer TA, Lapp WS. J Immunol; 1986 Dec 01; 137(11):3420-7. PubMed ID: 3537120 [Abstract] [Full Text] [Related]
10. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. Drobyski WR, Majewski D, Hanson G. Biol Blood Marrow Transplant; 1999 Dec 01; 5(4):222-30. PubMed ID: 10465102 [Abstract] [Full Text] [Related]
11. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets. Hirano M, Arase H, Arase-Fukushi N, Ogasawara K, Iwabuchi K, Miyazaki T, Good RA, Onoé K. Cell Immunol; 1993 Oct 01; 151(1):118-32. PubMed ID: 8402923 [Abstract] [Full Text] [Related]
12. The influence of the age of donors and recipients on the regional graft-versus-host reaction in mice. Skowron-Cendrzak A, Kubera M, Bubak-Satora M, Godowicz W. Arch Immunol Ther Exp (Warsz); 1991 Oct 01; 39(3):185-91. PubMed ID: 1810211 [Abstract] [Full Text] [Related]
13. Inhibition of graft-versus-host-reaction (GVHR) by in vitro incubation of donor lymphocytes with thymic or splenic chalone (s). Kiger N, Florentin I, Garcia-Giralt E, Mathé G. Exp Hematol; 1973 Oct 01; 1(1):22-8. PubMed ID: 4153630 [No Abstract] [Full Text] [Related]
14. [Status of T- and B-lymphocytes in long living CBA--F1 (CBA X C57BL/6) chimeras]. Cherniakhovskaia IIu, Nesterenko VG, Filitis LN, Fontalin LN, Novikova TK. Biull Eksp Biol Med; 1978 Aug 01; 86(8):197-200. PubMed ID: 28802 [Abstract] [Full Text] [Related]
15. Mortality of radiation chimeras in relation to the number of transplanted bone marrow and lymph node cells. Vos O. J Natl Cancer Inst; 1966 Mar 01; 36(3):431-43. PubMed ID: 18630319 [Abstract] [Full Text] [Related]
16. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells. Palathumpat V, Holm B, Dejbakhsh-Jones S, Strober S. J Immunol; 1992 May 15; 148(10):3319-26. PubMed ID: 1578152 [Abstract] [Full Text] [Related]
17. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice]. Li Y, Guo K, Chen Y, Song Z, Li J, Deng L. Zhonghua Xue Ye Xue Za Zhi; 2002 Aug 15; 23(8):411-4. PubMed ID: 12411044 [Abstract] [Full Text] [Related]
18. Rat-mouse radiation chimeras: characterization of an antibody-mediated graft-vs-host reaction. Kateley JR, Gengozian N. J Immunol; 1975 Jan 15; 114(1 Pt 1):125-32. PubMed ID: 234495 [Abstract] [Full Text] [Related]
19. The effect of ultraviolet irradiation on the localization of syngeneic and allogeneic lymphoid cells and on alloimmunogenicity. Milton JD. Immunology; 1981 Oct 15; 44(2):281-7. PubMed ID: 7298068 [Abstract] [Full Text] [Related]